How to recognize PCOS: results of a web-based survey at IVF-worldwide.com

The diagnosis of polycystic ovary syndrome (PCOS) remains a topic of ongoing debate among clinicians. While several diagnostic criteria have been proposed, their adoption varies across medical centers. Prior research has shown that diagnostic standards differ regionally and by specialty. No prior work had resolved how diagnostic tools beyond standard criteria are used in practice. This gap motivated a survey of global IVF centers to assess current diagnostic practices. Physicians often rely on a combination of clinical, biochemical, and imaging findings. However, the extent to which diagnostic tools outside traditional criteria are used is not well understood. This study aimed to address that uncertainty. The variability in diagnostic approaches suggests a need for updated consensus guidelines.

The goal of this study was to evaluate the diagnostic criteria and tools used by fertility specialists to identify PCOS. The specific problem addressed is the lack of global consensus on PCOS diagnosis. The motivation for the study stems from the need to understand how physicians interpret and apply existing diagnostic standards. The researchers aimed to determine whether diagnostic tools outside traditional criteria are commonly used. The study also sought to assess whether ultrasound findings alone are sufficient for diagnosis. The survey was designed to capture data from a broad geographic sample of IVF centers. The researchers focused on identifying trends in diagnostic practices across countries. The results could inform future efforts to standardize PCOS diagnosis.

The study involved a retrospective analysis of a web-based survey. The survey was posted on IVF-worldwide.com from September 1 to September 30, 2010. Responses were collected from 262 IVF centers in 68 countries. The survey asked about diagnostic criteria and tools used to diagnose PCOS. Physicians were asked to report which classification systems they applied. The survey also inquired about the use of specific laboratory tests and imaging findings. Data were analyzed to determine the frequency of each diagnostic approach. The study focused on identifying patterns in the use of Rotterdam, NIH, and other criteria.

The most commonly used diagnostic criteria were the Rotterdam criteria, reported by 82% of respondents. The NIH criteria were used by 8%, and the Androgen Excess Society criteria by 3%. Other diagnostic systems were reported by 7% of centers. Fifty-eight percent of physicians evaluated the LH/FSH ratio in addition to androgen levels. Twenty-two percent measured anti-Müllerian hormone as part of the diagnostic process. Seventy-four percent assessed impaired glucose tolerance in PCOS diagnosis. Sixty-four percent believed that polycystic ovaries on ultrasound with anovulation and normal prolactin were sufficient for diagnosis. These findings suggest that many physicians use tools not included in standard criteria.

The study found that the majority of IVF centers use the Rotterdam criteria to diagnose PCOS. However, a significant proportion of physicians also use other diagnostic tools and criteria. The authors suggest that the current diagnostic criteria may not fully capture the clinical diversity of PCOS. The findings indicate a need for ongoing evaluation of diagnostic standards. The authors propose that a consensus definition could improve diagnostic consistency. The study highlights the importance of considering ultrasound findings and metabolic markers. The results suggest that diagnostic approaches vary widely across centers. The authors emphasize the need for updated guidelines to ensure accurate diagnosis.